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Three copper(II) complexes, Cu(Sal-Gly)(phen), Cu(Sal-Gly)phea-
mine, Cu(Sal-Gly)phepoxy were synthesized and characterized for
their anticancer properties and mechanism of action (Acilan et al.,
in press) [1]. Here, we provide supporting data on colon cancer cell
lines complementing our previous ﬁndings in cervix cells. This
paper also contains a data table for the fold changes and p-values
of all genes analyzed in this study via a custom RT-qPCR array. All
compounds induced DNA damage (based on 8-oxo-guanidine,
ɣH2AX staining in cells) and apoptosis (based on elevated DNA
condensation/fragmentation, Annexin V staining, caspase 3/7
activity and mitochondrial membrane depolarization) in HCT-116
colon cancer cells. The increase in oxidative stress was also further
conﬁrmed in these cells. Further interpretation of the data pre-
sented here can be found in the article entitled “Synthesis, biolo-
gical characterization and evaluation of molecular mechanisms ofvier Inc. This is an open access article under the CC BY license
/j.bbagen.2016.10.014
.
. Acilan), icorreia@tecnico.ulisboa.pt (I. Correia).
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C. Acilan et al. / Data in Brief 9 (2016) 1160–1174 1161novel copper complexes as anticancer agents” (Acilan et al., in
press) [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Chemistry, Biology
ore speciﬁc sub-
ject areaCopper(II) complexes, Molecular biology, Cancer biology, Drug developmentype of data Table, microscopic image, graph, ﬁgure, scheme
ow data was
acquiredMicroscopy (Leica DMI 6000), Circular dichroism (Jasco 720), Electron Para-
magnetic Resonance (Bruker ESP 300E), UV–vis absorption (Perkin Elmer
Lambda 35), Flow cytometry (Muse Cell Analyzer, EMD Millipore)ata format Analyzed
xperimental
factorsNonexperimental
featuresValidation of the DNA binding properties of the presented Cu-complexes,
apoptosis, oxidative stress and DNA damage induced by these complexes in
human colon cancer cellsata source
locationKocaeli/Turkey and Lisbon/Portugalata accessibility Data are supplied with this article.D
Value of the data
 The data allows evaluating the stability of the Cu-complexes in aqueous buffers.
 The presented data displays evidence for the potential anticancer activity of Cu-complexes in
human colon carcinoma HCT-116 cells. Therefore, the ﬁndings in our original article are not speciﬁc
for only one cell line, but rather more general.
 The table may be valuable in determining/comparing potential molecular targets of other Cu-
complexes.
 The data may give insight for researchers to design better therapeutic agents and offer a base for
comparison between different compounds.1. Data
There is still a great surge for potent anticancer agents with well-described activity. In today's
world, most successful drugs ﬁnd their place in the market among thousands of molecules, which
were initially synthesized by the educated design of novel molecules with the aim of obtaining
ameliorated properties. Therefore, data describing how different molecules act in different types of
cells, become of great use. The desired function of anticancer drugs is inhibition of cell proliferation or
survival, preferably with activity in cells with different genetic backgrounds, since every cancer is also
divergent from one another. Here, we demonstrate the molecular mechanism of action of three
different Cu-compounds (see Scheme 1) in HCT-116 cells supporting our previous ﬁndings with HeLa
cells. We also disclose the full list of genes with fold change and exact p-values of our RT-qPCR
analysis in response to Cu(Sal-Gly)(pheamine), the most speciﬁc compound against cancer cells
(Table 1).
Cu(Sal-Gly)(phepoxy)Cu(Sal-Gly)(pheamine)Cu(Sal-Gly)(phen)
Scheme 1. Formulation of the complexes.
Table 1
List of genes studied in the RT-qPCR array. Three housekeeping genes were used in each experiment and each gene was
normalized to the average of housekeeping genes. Fold change was calculated as the fold increase compared to untreated
controls. An average of two independent experiments (each done in duplicate) is shown on the Table. Standard (Std) errors
represent deviations from the mean, and the p-values were calculated using paired samples t-test using SPSS 17.0 software.
Only one gene, Harakiri, was found to be statistically signiﬁcant above the cut-off value of 1.5 fold.
Gene name Fold change Std. deviation p-value
Akt1 0.782 0.080 0.160
Akt2 1.033 0.142 0.797
APAF1 0.766 0.195 0.339
ATG7 1.029 0.036 0.465
ATM 0.841 0.103 0.274
ATR 0.968 0.199 0.858
AURKA 1.173 0.312 0.577
BAG1 1.048 0.028 0.243
BAG3 1.060 0.158 0.688
BAG4 1.163 0.386 0.657
Bak1 0.874 0.313 0.670
Bax 1.076 0.511 0.867
Bcl2 1.326 0.381 0.439
BCL2A1 ND ND ND
BCL10 0.778 0.315 0.501
BCL2L2 1.221 0.158 0.299
BCL2L10 1.309 0.841 0.695
BCLAF1 0.720 0.234 0.340
Bcl-xL 1.148 0.306 0.619
BECN1 1.312 0.322 0.402
BFAR 0.954 0.070 0.527
BIRC2 0.760 0.202 0.342
BIRC3 0.927 0.197 0.692
BIRC4 1.000 0.145 1.000
BIRC6 0.965 0.022 0.262
BIRC8 ND ND ND
Bid 1.091 0.323 0.758
Bik 0.926 0.451 0.856
Bim 1.203 0.332 0.546
BMI1 0.799 0.083 0.181
BNIP1 1.188 0.316 0.556
BNIP2 1.236 0.774 0.740
BNIP3 0.713 0.273 0.376
BNIP3L 0.745 0.261 0.398
CASP2 0.912 0.316 0.761
CASP3 0.695 0.199 0.274
CASP4 0.923 0.105 0.492
CASP5 1.903 2.615 0.711
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Table 1 (continued )
Gene name Fold change Std. deviation p-value
CASP6 0.995 0.088 0.949
CASP7 0.763 0.062 0.117
CASP8 0.575 0.219 0.223
CASP9 0.757 0.576 0.657
CASP10 1.113 0.028 0.112
CASP14 2.676 2.644 0.535
CAT 1.082 0.178 0.633
CDC2 1.144 0.142 0.386
CDC25A 0.852 0.233 0.535
CDK2 0.817 0.109 0.251
CDK4 1.052 0.212 0.788
DCR 17.927 16.253 0.380
DR4 0.867 0.041 0.134
DR5 0.953 0.068 0.507
ERCC1 0.682 0.802 0.675
ERCC3 0.893 0.114 0.413
FADD 0.930 0.036 0.221
Fas(TNFRSF6) 0.837 0.065 0.175
GPX1 1.160 0.466 0.713
GRB2 0.897 0.060 0.250
GSTP1 1.121 0.333 0.697
HRK 1.731 0.327 0.000
LIG4 0.794 0.112 0.233
MCL1 0.709 0.334 0.434
MDM2 0.702 0.396 0.480
MUTYH 1.241 0.202 0.341
NFKB1/p50 0.793 0.050 0.107
Noxa 1.150 0.269 0.576
Nox1 2.129 0.989 0.353
Nox4 3.428 3.769 0.530
OGG1 1.121 0.104 0.349
PRDX1 0.964 0.155 0.800
Puma(BBC3) 1.348 0.517 0.516
P53 1.450 0.195 0.189
RAD51 0.895 0.151 0.503
RAD52 1.042 0.009 0.090
RIPK2 1.050 0.109 0.633
SIRT2 0.886 0.946 0.893
SOD1 0.942 0.185 0.732
TNFRSF11B(OPG) 2.180 1.581 0.483
XPA 1.116 0.079 0.286
XRCC5 0.862 0.005 0.016
C. Acilan et al. / Data in Brief 9 (2016) 1160–1174 1163Most metallodrugs are not water soluble, and a small % or organic solvent is typically used in
biological studies with metal complexes. On the other hand, biomolecules and cells are very sensitive
to organic solvents. Therefore it is very important to check the stability of the complexes in aqueous
environments; to make sure the compounds will maintain their structure for the necessary time
period, without substantial degradation or precipitation prior to the biological evaluation, and to
evaluate the effect of the organic solvent in the biological molecules under study, e.g. DNA.
The complexes' stability in aqueous media (see Fig. 1) and organic solvents (Fig. 2) and was
conﬁrmed by measuring spectral changes within 1–2 h (UV–vis) and EPR (up to 24 h) after pre-
paration of the solutions. Circular dichroism spectra of CT-DNA in the absence and presence of dif-
ferent % (v/v) of DMSO allowed evaluating the % range of DMSO where no changes in DNA conﬁg-
uration are detected (Fig. 3). The effect of adding DNA to the complexes' solutions was also evaluated
by UV–vis spectroscopy (Fig. 4), which did not allow the determination of binding constants, but
clearly showed occurring changes.
Fig. 1. UV–vis absorption spectra measured with increasing time (time interval between spectra¼5 min) for solutions of the
Cu-complexes in PBS. (A) Cu(Sal-Gly)(phen) 20 μM (0.6% DMSO) total time¼55 min; (B) [Cu(Sal-Gly)(pheamine) 20 μM (0.6%
DMSO) total time¼55 min and (C) [Cu(Sal-Gly)(phepoxy) 60 μM (1% DMSO) total time¼100 min. Arrows indicate changes
with time.
C. Acilan et al. / Data in Brief 9 (2016) 1160–11741164The cytotoxicity of the Cu-complexes were veriﬁed using a different assay relying on the amount
of total proteins (Sulforhodamine B (SRB) Cell Viability Assay), as an alternative to measurement of
change in mitochondrial dehydrogenase enzyme (MTT assay) in A-549, HCT-116 and HeLa cells
(Fig. 5).
Apoptosis was retested through the assessment of DNA condensation/fragmentation (Fig. 6),
Annexin V staining (Fig. 7), caspase 3/7 activity (Fig. 8), and mitochondrial membrane depolarization
(Fig. 9) in HCT-116 cells.
The increase in oxidative stress was evaluated by the measurement of intracellular DCFDA
(Fig. 10A) and the examination of oxidized glutathione (GSSG) by determining the ratio of GSSG/GSH
(Fig. 10B) in HCT-116 cells.
Consistent with our ﬁndings in HeLa cells, the compounds also appeared to induce oxidative DNA
damage as assessed by 8-oxo-Guanindine staining, the most common lesion in DNA in response to
oxidative stress (Fig. 11).
In addition to 8-oxo-Guanidine, there was an evident increase in double stranded DNA breaks as
judged by ɣH2AX staining in HCT-116 cells both using ﬂow cytometry (Fig. 12A) and microscopy
(Fig. 12B).
Fig. 2. First derivative X-band EPR spectra measured for frozen solutions (77 K) of the complexes with time. (A) Cu(Sal-Gly)
(phen) 4.0 mM in MeOH, and Cu(Sal-Gly)(pheamino) (B) and Cu(Sal-Gly)(phepoxy) 1.0 mM in DMSO.
C. Acilan et al. / Data in Brief 9 (2016) 1160–1174 11652. Experimental design, materials and methods
2.1. Calf thymus DNA binding experiments
UV-Visible absorption (UV–vis) spectra were recorded on a Perkin-Elmer Lambda 35 spectro-
photometer at room temperature. Circular dichroism (CD) spectra were recorded at 25 °C on a Jasco J-
720 spectropolarimeter with an UV–vis (180–800 nm) photomultiplier (EXEL-308). EPR spectra were
measured on a Bruker ESP 300E spectrometer at 77 K.
Millipore water was used for the preparation of TRIS and Phosphate Saline Buffer (PBS) buffers
(0.10 M, pH¼7.4). Calf thymus DNA (CT-DNA) was from Sigma (#D3664) and used as received. DNA
stock solutions were prepared by dissolution in TRIS or PBS buffer. The stock solutions of the
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Fig. 3. Circular dichroism spectra (1 cm optical path) of CT-DNA (60 μM) in the absence and presence of different % (v/v)
of DMSO.
Fig. 4. UV–vis absorption data: (A) Relative absorption values measured with time for solutions containing Cu(Sal-Gly)(phen)
(20 μM) with and without CT-DNA (1 mol equivalent); (B) UV–vis absorption spectra measured for a solution of Cu(Sal-Gly)
(pheamine) (40 μM) and increasing amounts of CT-DNA (from 0 to 180 μM); inset – changes observed in the ε values
(M1cm1) at 256 and 278 nm. (C) UV–vis absorption spectra measured for a solution of Cu(Sal-Gly)(phepoxy) (27 μM) and
increasing amounts of CT-DNA (from 0 to 28 μM). The arrow indicates increasing DNA concentration.
C. Acilan et al. / Data in Brief 9 (2016) 1160–11741166compounds were prepared by dissolving them in DMSO and dilution in TRIS buffer; they were used
within a few hours.
Circular dichroism studies were done with 3 mL solutions in quartz SUPRASILs cuvettes of 1 cm
optical path. The CT-DNA solution was prepared by dilution of the stock solution in PBS buffer and its
concentration (ca. 50–60 μM) was determined in each sample by measuring the absorbance at
24 h
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Fig. 5. Cytotoxicity of the Cu compounds as determined by SRB analysis. Cytotoxicity in response to three different Cu-com-
plexes was reevaluated using a different viability assay (SRB technique) upon increasing doses (0–12.5 mM) at different time
points (24 h, 72 h) in a subset of cancer cells (A-549, HCT-116, HeLa). x-axis: concentration in mM, y-axis: cell viability nor-
malized to untreated controls.
Control Cu(Sal-Gly)(pheamine)
Cu(Sal-Gly)(phen)Cu(Sal-Gly)(phepoxy)
Fig. 6. Changes in nuclear morphology in response to Cu complexes. HCT-116 cells displayed typical features of apoptosis such
as fragmentation and condensation. HCT-116 cells treated with 12.5 μM of Cu complexes are shown in the ﬁgure. Insets indicate
enlarged views of selected cells exhibiting these features.
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Control Cu(Sal-Gly)(phen)Cu(Sal-Gly)(pheamine) Cu(Sal-Gly)(phepoxy)
Fig. 7. Annexin V/PI staining supports apoptotic form of cell death in response to Cu compounds. HCT-116 cells were treated
with the Cu complexes and were stained with Annexin V/dead cell marker and counted with a ﬂow cytometer as described in
materials and methods. (A) Representative plots for HCT-116 cells following 24 h drug exposure are shown in the ﬁgure. (B) The
graphs represent averages from 2 independent experiments from 24 h of exposure (left graph) and 48 h of exposure (right
graph), where 10.000 cells were scored. x-axis: % cells, y-axis: name of the drug, NC: negative control, mock treated cells.
C. Acilan et al. / Data in Brief 9 (2016) 1160–11741168260 nm, prior to addition of the Cu-complexes' stock solutions in DMSO (ca. 2.0–3.0 mM) to obtain
each Cu:DNA ratio. UV–vis absorption titrations were done by adding aliquots of the DNA stock
solution in PBS to solutions of the complexes (20 to 60 μM) in PBS (with 1% or less DMSO).
2.2. Cell culturing, drug treatment
All cancer cells (A-549, HCT-116, HeLa) were maintained in Dulbecco's Modiﬁed Eagle Medium/F12
(DMEM/F12, Sigma-Aldrich, #D0547) supplemented with fetal bovine serum (FBS, 5% for cancer cells
and 10% for normal cells, Biochrom, #S0415) and penicillin/streptomycin (Biochrom, #A2212), and
incubated at 37 °C, in 5% CO2. For viability assays, 5–8103 cells (70–80% conﬂuency depending on
the cell line) were seeded in 96-well plates in regular culture medium, overnight. The following day,
serial dilutions of complexes, Cu(Sal-Gly)(pheamine), Cu(Sal-Gly)(phepoxy) and Cu(Sal-Gly)(phen)
(0.19–12.5 mM), were freshly prepared and added to the cells. After 24 or 72 h, cell viability was
measured using MTT reagent (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
(Sigma, #M5655) as described before [2].
2.3. Sulforhodamine B (SRB) cell viability assay
For SRB assay, 5–8103 cells (70–80% conﬂuency depending on the cell line) were seeded in 96-
well plates in regular culture medium in triplicate, overnight. The following day, serial dilutions of
Control Cu(Sal-Gly)(phen)Cu(Sal-Gly)(pheamine) Cu(Sal-Gly)(phepoxy)
Fig. 8. Analysis of caspase 3/7 activity using a ﬂow cytometric assay. HCT-116 cells were treated with the Cu-complexes and
were stained using Caspase 3/7 kit and counted with a ﬂow cytometer as described in materials and methods.
(A) Representative plots for HCT-116 cells following 48 h drug exposure are shown in the ﬁgure. (B) The graphs represent
averages from 2 independent experiments from 24 h of exposure (left graph) and 48 h of exposure (right graph), where 10.000
cells were scored. x-axis: % cells, y-axis: name of the drug, NC: negative control, mock treated cells.
C. Acilan et al. / Data in Brief 9 (2016) 1160–1174 1169complexes, Cu(Sal-Gly)(pheamine), Cu(Sal-Gly)(phepoxy) and Cu(Sal-Gly)(phen) (0.19–12.5 mM),
were freshly prepared and added to the cells. After 24 or 72 h, viable cells were ﬁxed with the 50%
trichloroacetic acid (TCA) at a ﬁnal concentration of 10%. Plates were kept at 4 °C for 1 h, the
supernatant was discarded and the plate was washed with deionized water ﬁve times. TCA-ﬁxed cells
were stained with SRB solution (0.4% in 1% acetic acid) for 30 min at room temperature (RT). Unbound
SRB was removed by washing with 1% acetic acid and air-dried. Bound SRB stain was solubilized with
Tris base solution (10 mM, pH:10.0), and plates were left on a shaker (10 min, 150 rpm). Absorbance
was read by a spectrophotometer at 570 nm.2.4. Detection of apoptosis
Apoptosis was detected though DNA condensation/fragmentation analysis using immuno-
ﬂuorescence staining (Leica DMI 6000 microscope) as described in [3]. Increase in Annexin V staining,
caspase 3/7 activity and mitochondrial membrane depolarization were determined using the Muse
Cell Analyzer (Millipore, Hayward, CA, USA) following manufacturer's protocols (Annexin V/Dead Cell
kit MCH100105, Caspase 3/7 kit MCH100108, Muse MitoPotential kit MCH100110 respectively) and
the details of the protocols are deﬁned further in [1].
Control Cu(Sal-Gly)(phen)Cu(Sal-Gly)(pheamine) Cu(Sal-Gly)(phepoxy)
Fig. 9. Induction of MMP in response to Cu complexes. HCT-116 cells were treated with the Cu complexes and were stained
using MitoPotential kit and counted with a ﬂow cytometer as described in materials and methods. (A) Representative plots for
HCT-116 cells following 48 h drug exposure are shown in the ﬁgure. (B) The graphs represent averages from 2 independent
experiments from 24 h of exposure (left graph) and 48 h of exposure (right graph), where 10.000 cells were scored. x-axis: %
cells, y-axis: name of the drug, NC: negative control, mock treated cells.
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Total reactive oxygen species were measured using using 20,70–dichloroﬂuorescein diacetate
(DCFDA, Sigma, cat # D6883) following the protocol described in [1]. The cellular effects were
determined through oxidation of Glutathione via measurement of GSSSG/GSH ratio (Promega,
Madison, WI, USA, GSH/GSSG Glo assay kit) following manufacturer's protocols with a slight mod-
iﬁcation [1].
2.6. Immunoﬂuorescence staining
For immunoﬂuorescence, HCT-116 cells were ﬁxed in freshly prepared 4% paraformaldehyde for
15 min at RT, permeabilized in 0.3% Triton X-100/PBS (1 h, RT), blocked in 0.2% gelatin (RT) and
stained with ɣH2AX (Cell Signaling, #9718 S, 1:400) or 8-oxo-Guanine (EMD Millipore, MAB3560,
1:100) antibodies overnight at 4 °C.
2.7. ɣH2AX assay for the assessment of DNA damage using ﬂow cytometry
HCT-116 cells were exposed to the Cu-complexes at the IC90 concentration for 12 h and stained
using Muse ɣH2AX Activation Dual Detection (kit MCH200101, Millipore, Darmstadt, Germany) as
described previously [1]. The data were acquired on the Muse Cell Analyzer (Millipore, Hayward,
CA, USA).
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Fig. 10. Increase in ROS in response to Cu-complexes. (A) Cells were pretreated with DCFDA with the indicated doses of Cu-
complexes for 6–72 h and ROS were measured as described in materials and methods. Averages from three replicates from
HCT-116 cells are shown in the graphs. y-axis: fold increase in DCFDA staining of cells relative to untreated controls, x-axis:
concentration of Cu-complexes (mM). Asterisks indicate signiﬁcance compared to untreated controls (paired samples t-test,
po0.05). (n:Cu(Sal-Gly)(pheamine), nn: Cu(Sal-Gly)(phepoxy), nnn: Cu(Sal-Gly)(phen)). (B) HCT-116 cells were treated with
12.5 mM of the Cu-complexes and lysed 24 h post incubation. The cellular GSSG/GSH (oxidized/reduced forms of glutathione)
levels were measured, and an increase in oxidation was observed with all three Cu-complexes. Signiﬁcance is indicated by
asterisks (paired samples t-test, po0.05).
C. Acilan et al. / Data in Brief 9 (2016) 1160–1174 1171
DNA 8-oxo-G 
C
on
tr
ol
C
u(
Sa
l-G
ly
)
(p
he
n)
C
u(
Sa
l-G
ly
)
(p
he
am
in
e)
C
u(
Sa
l-G
ly
)
(p
he
po
xy
)
Fig. 11. Oxidative DNA damage induced by the Cu-complexes. HCT-116 cells were treated with the 12.5 μM of Cu complexes for
24 h and were stained for DNA (blue) and 8-oxo-guanine (red), the most common lesion in response to oxidative stress. 8-oxo-
G staining was increased upon treatment with all Cu complexes.
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Fig. 12. Induction DNA double strand breaks as a result of treatment with the Cu-complexes. (A) HCT-116 cells were treated
with IC90 values of the Cu complexes for 12 h, and were stained with both anti-phospho-Histone H2AX (Ser139) and anti-
Histone H2AX antibodies, and quantiﬁed using a ﬂow cytometer. Non-expressing quadrant indicates cells that do not express
H2AX antigen, inactivated quadrant indicates the cells expressing H2AX without phosphorylation and activated quadrant
indicates the ɣH2AX phosphorylated cells. The quantiﬁcation of results is shown in the graphs. (B) In order to visually
determine ɣH2AX positivity, HCT-116 cells were treated with 12.5 and 25 mM of the Cu complexes, stained for ɣH2AX and
observed under the ﬂuorescence microscope. Images were taken using 100x magniﬁcation.
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